BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8528743)

  • 1. Tumor-associated lymphocytes (TAL) are competent to produce higher levels of cytokines in neoplastic pleural and peritoneal effusions than those found in sera and are able to release into culture higher levels of IL-2 and IL-6 than those released by PBMC.
    Mantovani G; Macciò A; Versace R; Pisano M; Lai P; Esu S; Ghiani M; Dessì D; Turnu E; Santona MC
    J Mol Med (Berl); 1995 Aug; 73(8):409-16. PubMed ID: 8528743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-associated lympho-monocytes from neoplastic effusions are immunologically defective in comparison with patient autologous PBMCs but are capable of releasing high amounts of various cytokines.
    Mantovani G; Macciò A; Pisano M; Versace R; Lai P; Esu S; Massa E; Ghiani M; Dessì D; Melis GB; Del Giacco GS
    Int J Cancer; 1997 May; 71(5):724-31. PubMed ID: 9180137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships betxween Fas expression, activation molecule CD25, and functional activity of tumor-associated lymphomonocytes from neoplastic effusions.
    Mantovani G; Macciò A; Massa E; Lai P; Manca G; Mudu C; Versace R; Pusceddu G
    Oncol Rep; 1999; 6(1):235-9. PubMed ID: 9864435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer.
    Santin AD; Hermonat PL; Ravaggi A; Bellone S; Roman JJ; Smith CV; Pecorelli S; Radominska-Pandya A; Cannon MJ; Parham GP
    Gynecol Obstet Invest; 2001; 51(4):254-61. PubMed ID: 11408737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane-bound/soluble IL-2 receptor (IL-2R) and levels of IL-1 alpha, IL-2, and IL-6 in the serum and in the PBMC culture supernatants from 17 patients with hematological malignancies.
    Mantovani G; Macciò A; Lai P; Ghiani M; Turnu E; Del Giacco GS
    Cell Biophys; 1995 Aug; 27(1):1-14. PubMed ID: 7493395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Without prior stimulation, tumor-associated lymphocytes from malignant effusions lyse autologous tumor cells in the presence of bispecific antibody HEA125xOKT3.
    Strauss G; Gückel B; Wallwiener D; Moldenhauer G
    Clin Cancer Res; 1999 Jan; 5(1):171-80. PubMed ID: 9918216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Fas and Fas ligand and apoptosis in tumor-associated lymphocytes and in tumor cells from malignant pleural effusions.
    Sikora J; Dworacki G; Zeromski J
    Nat Immun; 1998; 16(5-6):244-55. PubMed ID: 11061592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of cytotoxic T lymphocyte function in malignant pleural effusion: interleukin-15 vs. interleukin-2.
    Chen YM; Ting CC; Peng JW; Yang WK; Yang KY; Tsai CM; Perng RP
    J Interferon Cytokine Res; 2000 Jan; 20(1):31-9. PubMed ID: 10670650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medroxyprogesterone acetate reduces the in vitro production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients.
    Mantovani G; Macciò A; Esu S; Lai P; Santona MC; Massa E; Dessì D; Melis GB; Del Giacco GS
    Eur J Cancer; 1997 Apr; 33(4):602-7. PubMed ID: 9274442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
    Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
    Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth and antigen recognition of tumor-infiltrating lymphocytes from human breast cancer.
    Hudson JM; Castilleja A; Murray JL; Honda T; Kudelka A; Singletary E; Wharton JT; Ioannides CG
    J Interferon Cytokine Res; 1998 Jul; 18(7):529-36. PubMed ID: 9712369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High serum levels of soluble IL-2 receptor, cytokines, and C reactive protein correlate with impairment of T cell response in patients with advanced epithelial ovarian cancer.
    Macciò A; Lai P; Santona MC; Pagliara L; Melis GB; Mantovani G
    Gynecol Oncol; 1998 Jun; 69(3):248-52. PubMed ID: 9648596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-specific and HLA-A2-restricted cytolysis by tumor-associated lymphocytes in human metastatic breast cancer.
    Linehan DC; Goedegebuure PS; Peoples GE; Rogers SO; Eberlein TJ
    J Immunol; 1995 Nov; 155(9):4486-91. PubMed ID: 7594611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of tumor-associated lymphocytes from gynecological tumors.
    Donnerstag B; Schröder W; Stegmüller M; Rüenauver A; Lissner R; Bender HG
    Clin Exp Obstet Gynecol; 1993; 20(3):137-44. PubMed ID: 8403420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A large quantity of CD3-/CD19-/CD16- lymphocytes in malignant pleural effusion from a patient with recurrent cholangio cell carcinoma.
    Onishi H; Morisaki T; Kuga H; Katano M; Doi F; Uchiyama A; Sugitani A; Wada J; Chijiiwa K; Tanaka M
    Immunol Invest; 2002 May; 31(2):121-35. PubMed ID: 12148948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The characterization of peritoneal and pleural exudate cells from malignant effusions.
    Oka M; Yoshino S; Hazama S; Shimoda K; Suzuki T
    Surg Today; 1993; 23(6):500-3. PubMed ID: 8102920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of an increase in soluble interleukin-2 receptor level in colorectal cancer and its biological regulating role in the physiological switching of the immune response cytokine network from TH1 to TH2 and back.
    Berghella AM; Pellegrini P; Del Beato T; Marini M; Tomei E; Adorno D; Casciani CU
    Cancer Immunol Immunother; 1998 Jan; 45(5):241-9. PubMed ID: 9439647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between DNA content, expression of Ki-67 antigen of tumor cells and immunophenotype of lymphocytes from malignant pleural effusions.
    Sikora J; Dworacki G; Trybus M; Batura-Gabryel H; Zeromski J
    Tumour Biol; 1998; 19(3):196-204. PubMed ID: 9591046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in cell population and tumor necrosis factor, interleukin-6, and interleukin-8 in malignant pleural effusions after treatment with intrapleural tetracycline.
    Lin CC; Liu CC; Lin CY
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1503-6. PubMed ID: 8503562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross regulation by IL-10 and IL-2/IL-12 of the helper T cells and the cytolytic activity of lymphocytes from malignant effusions of lung cancer patients.
    Chen YM; Yang WK; Ting CC; Tsai WY; Yang DM; Whang-Peng J; Perng RP
    Chest; 1997 Oct; 112(4):960-6. PubMed ID: 9377959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.